[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU8883998A - Pharmaceutical compositions for the treatment of ocular inflammations comprisingdexamethasone palmitate - Google Patents

Pharmaceutical compositions for the treatment of ocular inflammations comprisingdexamethasone palmitate

Info

Publication number
AU8883998A
AU8883998A AU88839/98A AU8883998A AU8883998A AU 8883998 A AU8883998 A AU 8883998A AU 88839/98 A AU88839/98 A AU 88839/98A AU 8883998 A AU8883998 A AU 8883998A AU 8883998 A AU8883998 A AU 8883998A
Authority
AU
Australia
Prior art keywords
comprisingdexamethasone
palmitate
treatment
pharmaceutical compositions
ocular inflammations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU88839/98A
Inventor
Yossi Bornstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMATEAM DEVELOPMENT Ltd
Original Assignee
PHARMATEAM DEV Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMATEAM DEV Ltd filed Critical PHARMATEAM DEV Ltd
Publication of AU8883998A publication Critical patent/AU8883998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU88839/98A 1997-08-28 1998-08-26 Pharmaceutical compositions for the treatment of ocular inflammations comprisingdexamethasone palmitate Abandoned AU8883998A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL121647 1997-08-28
IL12164797A IL121647A (en) 1997-08-28 1997-08-28 Pharmaceutical compositions for the treatment of ocular inflammation comprising dexamethasone palmitate
PCT/IL1998/000411 WO1999011270A1 (en) 1997-08-28 1998-08-26 Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate

Publications (1)

Publication Number Publication Date
AU8883998A true AU8883998A (en) 1999-03-22

Family

ID=11070569

Family Applications (1)

Application Number Title Priority Date Filing Date
AU88839/98A Abandoned AU8883998A (en) 1997-08-28 1998-08-26 Pharmaceutical compositions for the treatment of ocular inflammations comprisingdexamethasone palmitate

Country Status (7)

Country Link
EP (1) EP1009409A1 (en)
JP (1) JP2001514228A (en)
CN (1) CN1271288A (en)
AU (1) AU8883998A (en)
CA (1) CA2300850A1 (en)
IL (1) IL121647A (en)
WO (1) WO1999011270A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05000632A (en) * 2002-07-15 2005-03-31 Alcon Inc Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use.
US7767217B2 (en) * 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
PT1864667E (en) * 2006-06-01 2013-11-18 Novagali Pharma Sa Use of prodrugs for ocular intravitreous administration
KR101541416B1 (en) 2006-06-01 2015-08-03 산텐 에스에이에스 Use of a Steroid Prodrug for the Treatment of Disease of the Posterior Segment of the Eye
KR101805116B1 (en) * 2007-12-04 2017-12-06 산텐 에스에이에스 Compositions comprising corticosteroid prodrug such as dexamethasone palmitate for the treatment of eye disorders
CN108434090A (en) * 2017-02-14 2018-08-24 高药品股份有限公司 Using physiology fat as the steroids ointment of base

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS609726B2 (en) * 1980-05-15 1985-03-12 株式会社 ミドリ十字 steroid preparations
JPS62270521A (en) * 1986-05-16 1987-11-24 Green Cross Corp:The Flurbiprofen preparation for ophthalmic administration
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
JPH05124965A (en) * 1991-11-06 1993-05-21 L T T Kenkyusho:Kk Nasal and bronchial disease-therapeutic agent for local application

Also Published As

Publication number Publication date
IL121647A0 (en) 1998-02-08
WO1999011270A1 (en) 1999-03-11
IL121647A (en) 2001-07-24
CN1271288A (en) 2000-10-25
JP2001514228A (en) 2001-09-11
CA2300850A1 (en) 1999-03-11
EP1009409A1 (en) 2000-06-21

Similar Documents

Publication Publication Date Title
AU2053597A (en) Pharmaceutical compositions for the treatment of glaucoma
AU5945396A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
AU7547196A (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
AU7358398A (en) Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
AU6216296A (en) Pharmaceutical compositions
AU6513298A (en) Therapeutic compositions
AU5869796A (en) Micromechanical patch for enhancing the delivery of compound s through the skin
AU7572196A (en) Pharmaceutical formulations
AU9083098A (en) Diagnosis of ocular pathogens
AU698509B2 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
AU699020B2 (en) Liquid formulations of 1,2-benzisothiazolin-3-one
AU1774097A (en) Pharmaceutical compositions for the treatment of rhinitis
AU3107197A (en) Medicinal compositions for treating liver diseases
AU6858996A (en) Pharmaceutical compositions for the treatment of infectious diseases
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU5274096A (en) Pharmaceutical compositions
AU2027495A (en) Pharmaceutical composition for treating hemorrhoidal diseases
AU5053296A (en) Pharmaceutical agents for the treatment of Alzheimer's disease
AU7812794A (en) Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
AU8883998A (en) Pharmaceutical compositions for the treatment of ocular inflammations comprisingdexamethasone palmitate
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
AU5494298A (en) Pharmaceutical compositions for the treatment of the eye
AU5526196A (en) Compositions for the treatment of dandruff
AU5699396A (en) Compositions for the treatment of skin conditions
AUPN727595A0 (en) Therapeutic compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase